Stockscreener 앱 받기
1.13
6.61%
-0.08
전일 마감가:
$1.21
열려 있는:
$1.2
하루 거래량:
183.06K
Relative Volume:
1.02
시가총액:
$63.96M
수익:
-
순이익/손실:
$-131.52M
주가수익비율:
-0.6348
EPS:
-1.78
순현금흐름:
$-107.56M
1주 성능:
-8.13%
1개월 성능:
+34.84%
6개월 성능:
+62.31%
1년 성능:
-76.60%
1일 변동 폭
$1.10
$1.2386
1주일 범위
$1.10
$1.26
52주 변동 폭
$0.6101
$5.075
Prelude Therapeutics Inc Stock (PRLD) Company Profile
명칭
Prelude Therapeutics Inc
전화
(302) 467-1280
주소
175 INNOVATION BOULEVARD, WILMINGTON
PRLD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRLD
Prelude Therapeutics Inc
|
1.13 | 67.35M | 0 | -131.52M | -107.56M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-19 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-20 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-03-13 | 개시 | JMP Securities | Mkt Outperform |
| 2024-02-20 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-29 | 개시 | Jefferies | Buy |
| 2022-03-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-28 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-10-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-04-26 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2020-11-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-10-20 | 개시 | BofA Securities | Buy |
| 2020-10-20 | 개시 | Goldman | Neutral |
| 2020-10-20 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Prelude Therapeutics Inc 주식(PRLD)의 최신 뉴스
How hedge fund analytics apply to Prelude Therapeutics Incorporated stockJuly 2025 Reactions & Weekly Hot Stock Watchlists - Newser
What high frequency data says about Prelude Therapeutics IncorporatedWeekly Investment Recap & Community Supported Trade Ideas - Newser
Heatmap analysis for Prelude Therapeutics Incorporated and competitorsMarket Risk Analysis & Low Volatility Stock Suggestions - Newser
Visualizing Prelude Therapeutics Incorporated stock with heatmapsWeekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser
Strategies to average down on Prelude Therapeutics IncorporatedJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
Can Prelude Therapeutics Incorporated hit a new high this monthFed Meeting & Fast Gain Stock Tips - Newser
Long term hold vs stop loss in Prelude Therapeutics IncorporatedQuarterly Profit Summary & Smart Money Movement Alerts - Newser
Will Prelude Therapeutics Incorporated see short term momentum2025 Market Sentiment & Daily Stock Trend Reports - Newser
Understanding Prelude Therapeutics Incorporated’s price movementTrade Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Using data tools to time your Prelude Therapeutics Incorporated exit2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
What MACD signals say about Prelude Therapeutics Incorporated2025 Bull vs Bear & Verified Entry Point Signals - Newser
Prelude Therapeutics Incorporated stock volume spike explainedMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
Is Prelude Therapeutics Incorporated showing signs of accumulationWeekly Market Outlook & Weekly High Return Stock Forecasts - Newser
Sentiment analysis tools applied to Prelude Therapeutics Incorporated2025 Winners & Losers & Long-Term Growth Plans - Newser
Combining price and volume data for Prelude Therapeutics Incorporated2025 Market Overview & Technical Pattern Based Signals - Newser
Advanced analytics toolkit walkthrough for Prelude Therapeutics IncorporatedMarket Trend Report & Weekly Market Pulse Alerts - Newser
Developing predictive dashboards with Prelude Therapeutics Incorporated dataQuarterly Market Review & Technical Confirmation Alerts - Newser
Is Prelude Therapeutics Incorporated stock entering bullish territory2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Detecting price anomalies in Prelude Therapeutics Incorporated with AIJuly 2025 Recap & Entry Point Confirmation Signals - Newser
Will Prelude Therapeutics Incorporated continue its uptrend2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Does Prelude Therapeutics Incorporated fit your quant trading model2025 Market WrapUp & Long-Term Capital Growth Strategies - Newser
Price action breakdown for Prelude Therapeutics IncorporatedDividend Hike & Intraday High Probability Alerts - Newser
Real time scanner hits for Prelude Therapeutics Incorporated explainedPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - Newser
Is Prelude Therapeutics Incorporated stock reversal real or fakeWeekly Trend Report & Fast Gain Stock Tips - Newser
Published on: 2025-09-11 05:01:05 - Newser
heatmap analysis for prelude therapeutics incorporated and competitorsRisk Management & Technical Pattern Alert System - Newser
Tools to monitor Prelude Therapeutics Incorporated recovery probabilityQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Has Prelude Therapeutics Incorporated formed a bullish divergence2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
Is Prelude Therapeutics Incorporated still worth holding after the dipRecession Risk & Weekly Momentum Stock Picks - Newser
Market reaction to Prelude Therapeutics Incorporated’s recent news2025 Price Action Summary & AI Based Trade Execution Alerts - Newser
Quantitative breakdown of Prelude Therapeutics Incorporated recent move2025 Technical Overview & Smart Investment Allocation Tips - Newser
Prelude Therapeutics Inc (PRLD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prelude Therapeutics Inc 주식 (PRLD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna | CEO |
Mar 25 '25 |
Buy |
0.69 |
675,000 |
467,438 |
1,999,296 |
| Vaddi Krishna | CEO |
Mar 21 '25 |
Buy |
0.73 |
15,000 |
10,959 |
1,324,296 |
| Vaddi Krishna | CEO |
Mar 20 '25 |
Buy |
0.73 |
5,416 |
3,950 |
1,309,296 |
| Vaddi Krishna | CEO |
Mar 14 '25 |
Buy |
0.75 |
29,999 |
22,631 |
1,294,774 |
| Vaddi Krishna | CEO |
Mar 17 '25 |
Buy |
0.75 |
9,106 |
6,829 |
1,303,880 |
| Vaddi Krishna | CEO |
Mar 13 '25 |
Buy |
0.72 |
50,000 |
35,820 |
1,264,775 |
| Vaddi Krishna | CEO |
Mar 12 '25 |
Buy |
0.71 |
47,500 |
33,744 |
1,214,775 |
| Vaddi Krishna | CEO |
Dec 31 '24 |
Buy |
1.21 |
5,000 |
6,044 |
142,553 |
| Vaddi Krishna | CEO |
Dec 30 '24 |
Buy |
1.20 |
10,000 |
12,000 |
137,553 |
| Combs Andrew | Chief Chemistry Officer |
Dec 23 '24 |
Buy |
1.37 |
60,000 |
82,002 |
377,623 |
0.93%
0.10%
자본화:
|
볼륨(24시간):